MAFA
IONS icon

MJT & Associates Financial Advisory’s Ionis Pharmaceuticals IONS Stock Holding History

MJT & Associates Financial Advisory’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-15
Closed -$1.19K – 455
2026
Q2 		$1.19K Buy
+15
New +$1.13K ﹤0.01% 414

Other funds holding IONS

WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

MJT & Associates Financial Advisory's IONS Position: Q3 2026 in Review

MJT & Associates Financial Advisory sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 15 shares — an estimated $1.19K sold.

MJT & Associates Financial Advisory first reported a position in IONS in Q2 2026 and held it in 1 quarter. The position peaked at $1.19K in Q2 2026. 11 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • MJT & Associates Financial Advisory reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • MJT & Associates Financial Advisory sold 15 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.19K.
  • MJT & Associates Financial Advisory first reported a position in Ionis Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • MJT & Associates Financial Advisory's Ionis Pharmaceuticals position peaked at $1.19K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.